These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831 [TBL] [Abstract][Full Text] [Related]
3. Predominance of activated, clonally expanded T helper type 17 cells within the CD4+ T cell population in psoriatic lesions. Lewis BJ; Rajpara S; Haggart AM; Wilson HM; Barker RN; Ormerod AD Clin Exp Immunol; 2013 Jul; 173(1):38-46. PubMed ID: 23607572 [TBL] [Abstract][Full Text] [Related]
5. Persistence of interleukin (IL)-17A+ T lymphocytes and IL-17A expression in treatment-resistant psoriatic plaques despite ustekinumab therapy. Jack C; Mashiko S; Arbour N; Bissonnette R; Sarfati M Br J Dermatol; 2017 Jul; 177(1):267-270. PubMed ID: 27599204 [No Abstract] [Full Text] [Related]
6. Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis. Killeen ME; Ferris L; Kupetsky EA; Falo L; Mathers AR J Immunol; 2013 Apr; 190(8):4324-36. PubMed ID: 23479230 [TBL] [Abstract][Full Text] [Related]
8. Enrichment of Polyfunctional IL-17-Producing T Cells in Paradoxical Psoriasis Skin Lesions. Moran B; Gallagher C; Tobin AM; Fletcher JM J Invest Dermatol; 2020 May; 140(5):1094-1097. PubMed ID: 31682840 [No Abstract] [Full Text] [Related]
9. Current understanding of the role of dietary lipids in the pathophysiology of psoriasis. Honda T; Kabashima K J Dermatol Sci; 2019 Jun; 94(3):314-320. PubMed ID: 31133503 [TBL] [Abstract][Full Text] [Related]
10. Critical role of the interleukin-23/T-helper 17 cell axis in the pathogenesis of psoriasis. Nakajima K J Dermatol; 2012 Mar; 39(3):219-24. PubMed ID: 22352845 [TBL] [Abstract][Full Text] [Related]
11. Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis. Sofen H; Smith S; Matheson RT; Leonardi CL; Calderon C; Brodmerkel C; Li K; Campbell K; Marciniak SJ; Wasfi Y; Wang Y; Szapary P; Krueger JG J Allergy Clin Immunol; 2014 Apr; 133(4):1032-40. PubMed ID: 24679469 [TBL] [Abstract][Full Text] [Related]
12. The IL23R A/Gln381 allele promotes IL-23 unresponsiveness in human memory T-helper 17 cells and impairs Th17 responses in psoriasis patients. Di Meglio P; Villanova F; Napolitano L; Tosi I; Terranova Barberio M; Mak RK; Nutland S; Smith CH; Barker JNWN; Todd JA; Nestle FO J Invest Dermatol; 2013 Oct; 133(10):2381-2389. PubMed ID: 23563201 [TBL] [Abstract][Full Text] [Related]
13. Use of brodalumab for the treatment of psoriasis and psoriatic arthritis. Kivelevitch DN; Menter A Immunotherapy; 2015; 7(4):323-33. PubMed ID: 25917624 [TBL] [Abstract][Full Text] [Related]
14. p38α signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation. Zheng T; Zhao W; Li H; Xiao S; Hu R; Han M; Liu H; Liu Y; Otsu K; Liu X; Huang G Sci Signal; 2018 Mar; 11(521):. PubMed ID: 29535261 [TBL] [Abstract][Full Text] [Related]
15. Coexistent skin lesions of vitiligo and psoriasis vulgaris. Immunohistochemical analyses for IL-17A-producing cells and regulatory T cells. Ono S; Tanizaki H; Otsuka A; Endo Y; Koyanagi I; Kataoka TR; Miyachi Y; Kabashima K Acta Derm Venereol; 2014 May; 94(3):329-30. PubMed ID: 24129673 [No Abstract] [Full Text] [Related]
16. Psoriasis and other Th17-mediated skin diseases. Tokura Y; Mori T; Hino R J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422 [TBL] [Abstract][Full Text] [Related]
17. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model. Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414 [TBL] [Abstract][Full Text] [Related]
18. Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies. Bugaut H; Aractingi S Front Immunol; 2021; 12():621956. PubMed ID: 33717124 [TBL] [Abstract][Full Text] [Related]
19. Significance of IL-17A-producing CD8 Kurihara K; Fujiyama T; Phadungsaksawasdi P; Ito T; Tokura Y J Dermatol Sci; 2019 Jul; 95(1):21-27. PubMed ID: 31300254 [TBL] [Abstract][Full Text] [Related]